Age Stratified Risk Prediction of Invasive versus In-situ Breast Cancer: A Logistic Regression Model - PowerPoint PPT Presentation

About This Presentation
Title:

Age Stratified Risk Prediction of Invasive versus In-situ Breast Cancer: A Logistic Regression Model

Description:

Age Stratified Risk Prediction of Invasive versus In-situ Breast Cancer: A Logistic Regression Model Mehmet Ayvaci1,2 Oguzhan Alagoz1,Jagpreet Chhatwal3, – PowerPoint PPT presentation

Number of Views:100
Avg rating:3.0/5.0
Slides: 23
Provided by: Industrial74
Category:

less

Transcript and Presenter's Notes

Title: Age Stratified Risk Prediction of Invasive versus In-situ Breast Cancer: A Logistic Regression Model


1
Age Stratified Risk Prediction of Invasive versus
In-situ Breast Cancer A Logistic Regression
Model
  • Mehmet Ayvaci1,2
  • Oguzhan Alagoz1,Jagpreet Chhatwal3,
  • Mary Lindstrom4,Houssam Nassif5,Elizabeth S
    Burnside2

1Industrial and Systems Engineering,
UW-Madison 2Radiology, UW-Madison 3Merck Research
Labaratories 4Biostatistics 5Computer Science,
UW-Madison
2
Breast Anatomy
  • Breast profile
  • A ducts
  • B lobules
  • C dilated section of duct to hold milk
  • D nipple
  • E fat
  • F pectoralis major muscle
  • G chest wall/rib cage
  • Enlargement
  • A normal duct cells
  • B basement membrane
  • C lumen (center of duct)

www.breastcancer.org
3
Progression of Breast Cancer
Atypical ductal hyperplasia
Normal duct
Invasive ductal carcinoma
Typical ductal hyperplasia
Ductal carcinoma in situ (DCIS)
  • Age Stratified Risk Prediction of
  • Invasive vs In-situ Breast Cancer
  • A Logistic Regression Model

4
Age Stratification forInvasive vs In-situ Breast
Cancer
  • Primary modality of screening or diagnosis
    Mammography
  • Performs differently in different age groups
  • Sensitivity Age
  • lt40 ? 54
  • 40-49 ? 77
  • 50-65 ? 78
  • gt65 ? 81
  • Sensitivity Breast Density
  • 68 vs. 85
  • Younger vs. older

5
Age Stratification forInvasive vs In-situ Breast
Cancer
  • Primary modality of detecting type of breast
    cancer Biopsy
  • Incidence of DCIS has increased since adoption of
    mammography
  • DCIS has favorable prognosis will often not
    cause mortality for years
  • PPV of biopsy 20

6
Age Stratification forInvasive vs In-situ Breast
Cancer
  • Invasive vs. DCIS distinction important because
  • Requires different treatment
  • Life expectancy difference in older and younger
    women
  • Over diagnosis which does not correspond to
    reduced mortality
  • Breast cancer less aggressive in older women
  • Invasive procedures more risky in older women
  • Resources could be better spent on more serious
    co-morbidities

7
Purpose and Methods
  • Develop a risk prediction model for prospective
    differentiation of DCIS versus invasive breast
    cancer
  • Measure and compare model performance for
    different age groups

8
Purpose and Methods Contd.
Measure Risk Of Invasive Cancer Given Information
Risk Assessment Tools
Clinical Implications
Validation of The Model
ROC PR Curves, Statistical Testing
Optimize Sequential Decision Making in the
Context Of Breast Cancer Screening
Markov Decision Processes
Clinical Implications
9
Structure of Data Used
NMD National Mammography Database Format
Radiologists Overall Assessment of the
Mammogram with Some Repeat to the Structured Part
Free Text
Structured
Demographic Factors
Mammographic Descriptors
Turned into Structured format using Natural
Language Processing
BIRADS descriptors
10
Methods Processing Free Text
  • Information retrieval from free text given a
    standardized lexicon
  • Parse sentences to detect BIRADS descriptors
    using Natural Language Processing in PERL
  • Test on a set of 100 which is manually populated
  • 97.7 Precision
  • 95.5 Recall

11
Data in Detail
Free Text
Features Extracted Using NLP
12
Summary of Data
  • 1475 Diagnostic Mammograms ? 1378 Patients
  • 1298 patients with single mammogram
  • 81 patients with 2 mammograms
  • 5 patients with three mammograms
  • 1063 cases invasive vs. 412 DCIS
  • Age range ? 27 to 97 with
  • Mean 59.7 and standard deviation 13.4

13
Methods Performing Logistic Regression
  • Regress with a dichotomous outcome, where the
    patient is known to have malignant condition,
    i.e.
  • Invasive or
  • DCIS
  • Stratified data into 3 groups
  • Overall Model ?LR 1475 records
  • Age Less Than 50 ? LRyoung 374 records
  • Age Greater Than 65 ? LROld 533 records
  • Used stepwise regression to find the appropriate
    models. Possibility of interactions were
    investigated

P(InvasiveDemographic Factors, Mammographic
Descriptors)
14
Methods Validation Technique
  • n fold cross-validation
  • Leave-one-out

15
Methods Measuring Performance
  • Sensitivity vs. 1-Specificity at all thresholds
  • Sensitivity True Positive Rate
  • Specificity True Negative Rate
  • Thresholds Probability above which call
    Invasive
  • AUC Area Under the Curve

Sensitivitya/(ac) Specificity d/(bd)
16
Results LR
  • Overall model significant at p-valuelt0.01
  • Not enough power to justify inclusion of
    interaction terms (Over-fitting)
  • Acceptable ROC
  • Decreasing trend in Error rates

17
Results LRyoung vs. LRold
18
Results LRyoung vs. LRold
  • Difference in AUC 0.07
  • Significant at p-value 0.045

19
Results LRyoung vs. LRold
  • Improvement is in False Negatives

20
In Summary
  • Mammography is not perfect and performs better in
    older women.
  • There is a need for discriminating between
    invasive and DCIS to better manage the breast
    disease in the context of age and other
    comorbidities
  • An age based risk prediction model for assessing
    performance difference in discriminating
    invasive vs. DCIS is necessary
  • Such a model would enable physicians to make more
    informed decisions
  • Demonstration of performance difference and
    varying risk factors in different age cohorts
    justifies

21
Future Work
Measure Risk Of Invasive Cancer Given Information
Risk Assessment Tools
Clinical Implications
Validation of The Model
ROC PR Curves, Statistical Testing
Get in Literature
Markov Decision Processes
Optimize Sequential Decision Making in the
Context Of Breast Cancer Screening
Clinical Implications
Using POMDPs to Determine the Optimal Mammography
Screening Schedule From the Patient's
Perspective Presenting Author  Turgay
Ayer,University of Wisconsin Co-Author Oguzhan
Alagoz,Assistant Professor, University of
Wisconsin-Madison
22
Questions?
  • THANK YOU!
Write a Comment
User Comments (0)
About PowerShow.com